BACKGROUND: Necrotizing pancreatitis can be complicated by Necrotic Fluid Collections (NFC). Guidelines recommend waiting for 4 weeks from the onset of acute pancreatitis (AP) before considering endoscopic drainage. We aimed to compare outcomes and safety in patients undergoing early versus late drainage of NFC. METHODS: We performed a retrospective review of all patients who underwent Dual Modality Drainage (DMD) [combined endoscopic and percutaneous drainage] for NFC from January 2007 to December 2020. Patients were stratified into the "early" group (DMD < 28 days from AP onset) and were matched to "late" (DMD ≥ 28 days) drainage group using propensity- core-matching. Primary outcomes of interest were technical success and adverse events. Secondary outcomes included clinical success, late complication rates, and mortality. RESULTS: We identified 278 patients who underwent DMD for NFC. Thirty-nine belonged to the early group and were matched to 174 patients from the late group. Technical success was similar in both early and late groups (97.4% vs 99.4%: P = 0.244) as were the procedural and early post-procedural (< 14 days) adverse events rates (23.1% vs 27.6%: P = 0.565). Clinical success (92.3% vs 93.1%; P = 0.861) and late complication rates (23.1% vs 31.6%; P = 0.294) were similar. There were 2 deaths (5.7%) in the early vs. 9 (5.2%) in the late group, P = 0.991. CONCLUSIONS: When performed in a tertiary care center with expertise in therapeutic endoscopic ultrasound, early drainage of NFC appears to be feasible and safe. Further studies are needed to validate our results.
BACKGROUND: Necrotizing pancreatitis can be complicated by Necrotic Fluid Collections (NFC). Guidelines recommend waiting for 4 weeks from the onset of acute pancreatitis (AP) before considering endoscopic drainage. We aimed to compare outcomes and safety in patients undergoing early versus late drainage of NFC. METHODS: We performed a retrospective review of all patients who underwent Dual Modality Drainage (DMD) [combined endoscopic and percutaneous drainage] for NFC from January 2007 to December 2020. Patients were stratified into the "early" group (DMD < 28 days from AP onset) and were matched to "late" (DMD ≥ 28 days) drainage group using propensity- core-matching. Primary outcomes of interest were technical success and adverse events. Secondary outcomes included clinical success, late complication rates, and mortality. RESULTS: We identified 278 patients who underwent DMD for NFC. Thirty-nine belonged to the early group and were matched to 174 patients from the late group. Technical success was similar in both early and late groups (97.4% vs 99.4%: P = 0.244) as were the procedural and early post-procedural (< 14 days) adverse events rates (23.1% vs 27.6%: P = 0.565). Clinical success (92.3% vs 93.1%; P = 0.861) and late complication rates (23.1% vs 31.6%; P = 0.294) were similar. There were 2 deaths (5.7%) in the early vs. 9 (5.2%) in the late group, P = 0.991. CONCLUSIONS: When performed in a tertiary care center with expertise in therapeutic endoscopic ultrasound, early drainage of NFC appears to be feasible and safe. Further studies are needed to validate our results.
Authors: Hjalmar C van Santvoort; Olaf J Bakker; Thomas L Bollen; Marc G Besselink; Usama Ahmed Ali; A Marjolein Schrijver; Marja A Boermeester; Harry van Goor; Cornelis H Dejong; Casper H van Eijck; Bert van Ramshorst; Alexander F Schaapherder; Erwin van der Harst; Sijbrand Hofker; Vincent B Nieuwenhuijs; Menno A Brink; Philip M Kruyt; Eric R Manusama; George P van der Schelling; Tom Karsten; Eric J Hesselink; Cornelis J van Laarhoven; Camiel Rosman; Koop Bosscha; Ralph J de Wit; Alexander P Houdijk; Miguel A Cuesta; Peter J Wahab; Hein G Gooszen Journal: Gastroenterology Date: 2011-07-08 Impact factor: 22.682
Authors: Werner Hartwig; Sasa-Marcel Maksan; Thomas Foitzik; Jan Schmidt; Christian Herfarth; Ernst Klar Journal: J Gastrointest Surg Date: 2002 May-Jun Impact factor: 3.452
Authors: Guru Trikudanathan; Pierre Tawfik; Stuart K Amateau; Satish Munigala; Mustafa Arain; Rajeev Attam; Gregory Beilman; Siobhan Flanagan; Martin L Freeman; Shawn Mallery Journal: Am J Gastroenterol Date: 2018-10-02 Impact factor: 10.864
Authors: Peter A Banks; Thomas L Bollen; Christos Dervenis; Hein G Gooszen; Colin D Johnson; Michael G Sarr; Gregory G Tsiotos; Santhi Swaroop Vege Journal: Gut Date: 2012-10-25 Impact factor: 23.059
Authors: Nicholas Oblizajek; Naoki Takahashi; Sevda Agayeva; Fateh Bazerbachi; Vinay Chandrasekhara; Michael Levy; Andrew Storm; Todd Baron; Suresh Chari; Ferga C Gleeson; Randall Pearson; Bret T Petersen; Santhi Swaroop Vege; Ryan Lennon; Mark Topazian; Barham K Abu Dayyeh Journal: Gastrointest Endosc Date: 2020-01-18 Impact factor: 9.427
Authors: Marc G H Besselink; Hjalmar C van Santvoort; Vincent B Nieuwenhuijs; Marja A Boermeester; Thomas L Bollen; Erik Buskens; Cornelis H C Dejong; Casper H J van Eijck; Harry van Goor; Sijbrand S Hofker; Johan S Lameris; Maarten S van Leeuwen; Rutger J Ploeg; Bert van Ramshorst; Alexander F M Schaapherder; Miguel A Cuesta; Esther C J Consten; Dirk J Gouma; Erwin van der Harst; Eric J Hesselink; Lex P J Houdijk; Tom M Karsten; Cees J H M van Laarhoven; Jean-Pierre E N Pierie; Camiel Rosman; Ernst Jan Spillenaar Bilgen; Robin Timmer; Ingeborg van der Tweel; Ralph J de Wit; Ben J M Witteman; Hein G Gooszen Journal: BMC Surg Date: 2006-04-11 Impact factor: 2.102